Naloxone on release

Last Updated: 27 March 2022
4
Modules
20
Activities

About the Course

The course provides guidelines for naloxone provision upon release from prison and other custodial settings. The immediate time after release (“my first 48 hours out”) is a critical time for action, when the cooperation between prisons, healthcare providers and NGOs is key in ensuring continuity of care and where targeted interventions can save lives from overdose and build a path towards engagement into further treatment and rehabilitation for people who use drugs.

This course will:

  • advise policymakers of the practical steps necessary to introduce naloxone-on-release
  • inform programme managers of the benefits of naloxone-on-release and provide advice on implementation.

This course aims to support prison doctors, prison health care workers, NGOs, people who come into contact with people who use drugs, GPs, nurses, teachers, police, housing workers and social workers and mental health workers.

Since there are variations in policy and guidelines by country, the course cannot reflect country-specific regulations. It presents general principles, to complement, not replace, national and international guidelines.

The course is a product of the “My first 48 hours out – comprehensive approaches to pre and post-prison release interventions for drug users in the criminal justice system” project.

Here you will find basic information about the course, about opioid overdose, and about the "My first 48 hours out" project.

  1. 1.1

    Basic information and syllabus

    Reading

    This course is a product of the project “My first 48 hours out – comprehensive approaches to pre and post-prison release interventions for drug users in the criminal justice system”.

    It aims to promote the implementation of life-saving interventions in prison and upon release with specific reference to harm reduction, overdose prevention and the use of naloxone programmes.

  2. 1.2

    Opioid overdose

    Reading

    Globally, overdose is a leading cause of premature death among people who inject drugs and the overwhelming majority of overdose fatalities involve opioids*. Worldwide, an estimated 69 000 people die from opioid overdose each year (WHO, 2014).

  1. 2.1

    What is Naloxone and how it works?

    Reading

    Naloxone is a medication that reverses the effect of opioids. In an emergency overdose situation, it can be a lifesaver. In this section you will learn how it works, as well as how and when it should be used.

  2. 2.2

    Naloxone in European Countries

    Reading

    Examples and further details regarding Naloxone status and use in the following European countries: United Kingdom, France and Italy .

  3. 2.3

    Naloxone in European Countries, continued

    Reading

    Provision of Naloxone and related legislation in Norway, Denmark, Germany and Spain.

  1. 3.1

    Context and Introduction

    Reading

    Rates of drug-related deaths in Scotland are among the highest in Europe. In 2016, 867 people lost their lives to preventable overdose deaths, the majority of which were accidental (National Records of Scotland, 2017).

    In response to the rising number of opioid-related deaths, the Scottish Government introduced a National Naloxone Programme in 2010, which was launched in 2011.

  2. 3.2

    The Scottish Model - Practical Steps

    Reading

    The aim of the prison naloxone programme is to train prisoners in overdose prevention, intervention and naloxone during their sentence and to provide them with naloxone-on-release. It is delivered by NHS staff and peers, facilitated by the Scottish Prison Service.

    There are many steps along the ‘prisoner journey’ through their sentence where they have access to training. The steps listed here describe potential barriers and solutions to each phase.

  3. 3.3

    Peer Education, Effectiveness, and Areas of Improvement

    Reading

    The primary outcome for the effectiveness of the Scottish naloxone programme was to show a reduction in the number of opioid-related deaths within 4 weeks of liberation from prison.

    These deaths decreased by 36% from 9.8 to 6.3% during the evaluation period.

  4. 3.4

    Implementation Guide - Policy Makers

    Reading

    The following guidance is based on the experience and learning from the Scottish National Naloxone Programme.

  5. 3.5

    Implementation Guide - Practitioners

    Reading

When you finish the course, look into this section to find additional materials, both for self learning and for training others in lethal overdose prevention.

  1. 4.1

    My First 48 Hours Out

    PDF

    This comic booklet was produced in the framework of the EU co-funded project “My first 48 hours out” – comprehensive approaches to pre and post prison release interventions for drug users in the criminal justice system”, implemented by the University of Applied Sciences in Frankfurt.

  2. 4.2

    Overdose prevention - bibliography and references

    Reading

    List of recommended resources on the topic of overdose prevention and Naloxone.

  3. 4.3

    Use of Naloxone - followup interview/report

    PDF

    Example form to be used as a brief guide to follow up on Naloxone use cases.

  4. 4.4

    Naloxone Poster and Leaflet

    PDF

    Example of promotional materials produced in Scotland

  5. 4.5

    Overdose Prevention, Intervention and Naloxone Awareness Session

    PDF

    Example of an evaluation form for an "Overdose Prevention, Intervention and Naloxone Awareness Session"

  6. 4.6

    Naloxone Training - Sample Certificate

    PDF

    An example of a certificate to confirm completion of an overdose prevention, intervention and Naloxone training for trainers.

  7. 4.7

    Session Evaluation Template

    PDF

    Sample form of an overdose awareness or overdose intervention training session.

  8. 4.8

    Implementation checklist for Policy Makers and Practitioners

    PDF

    A brief one-page overdose prevention programme implementation checklist.

  9. 4.9

    Naloxone Training for Trainers

    PDF

    This course should provide an overview of drug-related deaths (DRDs) nationally and locally with an emphasis on overdose prevention, intervention and naloxone.
    It should explore the causes of DRDs, risk factors, high risk times, myths and how to identify the signs and symptoms of an overdose.
    There should be a focus on naloxone, its actions, kit assembly and administration with specific attention to the inclusion of naloxone in basic life support.

  10. 4.10

    One-to-one Naloxone Training Checklist

    PDF

    Checklist for a One-to-One Naloxone Training Session

In partnership with:
ISFF
FUAS
Correlation Network